Lux Venture Partners V
Major shareholder at Eikon Therapeutics · 5 reported transactions in 1 company · latest trade Feb 4, 2026
Their record
Across their whole record, 1 purchase can be measured; 0 did better than the S&P 500 over the next 6 months.
Typical move −35.9%, S&P 500 +9.5% over the same days.
Their trades
Bought | Feb 4, 2026 | Feb 5, 2026 close $15.00 → Oct 28, 2026 close $5.54. S&P 500 +13.6% over the same days. | ||
Bought | Feb 4, 2026 | Feb 5, 2026 close $15.00 → Oct 28, 2026 close $5.54. S&P 500 +13.6% over the same days. |
BoughtEikon Therapeutics
$2.5M
Feb 5, 2026 close $15.00 → Oct 28, 2026 close $5.54. S&P 500 +13.6% over the same days.
BoughtEikon Therapeutics
$2.5M
Feb 5, 2026 close $15.00 → Oct 28, 2026 close $5.54. S&P 500 +13.6% over the same days.